Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Lucrin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
This study optimized the preparation of electrosprayed microspheres containing leuprolide and developed an in vitro–in vivo… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2017
2017
Abstract A 3-month depot formulation of leuprolide acetate (Luphere 3M Depot) with a mean microsphere diameter of 22.3 μm was… Expand
2016
2016
The effect of treatment with Lucrin Depot (1 month), a microsphere gonadotrophin-releasing hormone agonist preparation, was… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
2015
2015
Objective. GnRH analogues (GnRHa) are used in the treatment of central precocious puberty (CPP). The purpose of this study was to… Expand
  • table 1
  • figure 1
  • table 3
  • table 4
  • table 5
2011
2011
Anaphylactic reactions to gonadotropin-releasing hormone (GnRH) agonists are exceedingly rare, but if they occur, they can be… Expand
2010
2010
We trialled the efficacy of various exogenous hormones to induce spermiation, courtship behavior, and spawning in the "endangered… Expand
  • figure 1
2008
2008
OBJECTIVE The aim of this study was to compare the efficacy of Lutrate 3.75 and 7.5 mg depot to marketed references Lucrin 3.75… Expand
2006
2006
A trial was conducted to evaluate the effect of pre-treatment with a GnRH agonist (GnRHa) on the superovulatory response in Boer… Expand
  • table 1
2003
2003
The aim of this study was to compare vertebral bone mass values of patients with central precocious puberty (CPP) with healthy… Expand
  • table 1
  • figure 1
  • figure 2